Muthukumarasamy Raja/LinkedIn
Aug 13, 2026, 18:31
Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
Muthukumarasamy Raja, Managing Director at GeniusArena Software B.V., shared a post on LinkedIn:
“Plasma is essential in severe bleeding because it replaces lost blood volume and provides clotting factors that help stop hemorrhage.
Yet, traditional plasma was difficult to use in emergencies because it required freezing, lengthy thawing, and strict cold-chain storage.
The FDA’s 2026 approval of EZPLAZ freeze-dried plasma represents a real breakthrough in emergency care by making plasma rapidly available where and when it is needed most.
Join JobsReach Healthcare, the healthcare industry network, to join the conversation, share your knowledge, and discover healthcare insights and opportunities.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering
-
Aug 13, 2026, 16:07Jackie Kunzler: Accelerating Innovation in Blood Processing